Signaling Pathways - NO Donors / Precursors - AAT - angiogenesis - ErbB
清除全部
- B1543 Mubritinib (TAK 165)中文名: 木利替尼Target: ErbBSummary: HER2/ErbB2有效抑制剂
- A8375 AZD8931 (Sapitinib)中文名: 沙普替尼Target: EGFR|ErbBSummary: ErbB抑制剂
- A8319 Dacomitinib (PF299804, PF299)中文名: 达克替尼Target: ErbBSummary: HER抑制剂
- A8218 Lapatinib2 Citation中文名: 拉帕替尼Target: ErbBSummary: EGFR/HER2抑制剂
- A3850 TAK-2427 Citation中文名: 瑞沙托维Target: Toll-like receptors (TLRs)|NO Donors / Precursors|IL ReceptorsSummary: TLR 4信号抑制剂
- A4211 Lenalidomide (CC-5013)中文名: 来那度胺Target: angiogenesisSummary: 抗肿瘤药物,抑制血管生成。
- A4092 CUDC-1011 CitationTarget: Histone Deacetylases (HDACs)|EGFR|ErbBSummary: 多靶点HDAC抑制剂
- A8188 Atractyloside Dipotassium Salt1 Citation中文名: 苍术苷钾盐Target: AATSummary: AAT抑制剂